×

Placental stem cell populations

  • US 10,383,897 B2
  • Filed: 06/10/2015
  • Issued: 08/20/2019
  • Est. Priority Date: 12/29/2005
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical composition comprising a population of isolated adherent placental stem cells, dimethyl sulfoxide (DMSO), and albumin, wherein said placental stem cells:

  • express genes at a detectably higher level than an equivalent number of bone marrow-derived mesenchymal stem cells (BM-MSCs);

    wherein said genes comprise ELOVL2, ST3GAL6, ST6GALNAC5, or SLC12A8;

    wherein at least 70% of said placental stem cells are non-maternal in origin; and

    wherein said placental stem cells have been passaged between 3 and 10 times.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×